Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Prospective, Multicenter, Double-Blind, Sham-Controlled Study to Assess the MORPHEUSV Radiofrequency (RF) Device in the Treatment of Female Patients With Idiopathic Overactive Bladder (OAB) With Urge Incontinence and/or Urge-Predominant Mixed Incontinence

NCT07209397 is registered in ClinicalTrials.gov with InMode MD Ltd. as lead sponsor.

NCT NCT07209397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07209397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Prospective, Multicenter, Double-Blind, Sham-Controlled Study to Assess the MORPHEUSV Radiofrequency (RF) Device in the Treatment of Female Patients With Idiopathic Overactive Bladder (OAB) With Urge Incontinence and/or Urge-Predominant Mixed Incontinence
Lead sponsor
InMode MD Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
November 25, 2025
Completion date
November 30, 2027
Enrollment
202 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic overactive bladder, idiopathic overactive bladder with urinary incontinence, mixed urinary incontinence, mixed urinary incontinence (urge-predominant), overactive bladder, overactive bladder (oab), urge urinary incontinence